Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Lissoni

Showing results (31-40 of 287) with videos related to

Pageof 29
Sort By:
Journal of Experimental & Clinical Cancer Research : CR|January 23, 1999
Possible biological indicators of the response to recombinant tumour necrosis factor alpha in patients with advanced neoplasmsR Braczkowski, B Zubelewicz, W Romanowski, et al.
Journal of Pineal Research|April 1, 1992
Normalization of the light/dark rhythm of melatonin after prolonged subcutaneous administration of interleukin-2 in advanced small cell lung cancer patientsS Viviani, P Bidoli, S Spinazzé, et al.
Natural Immunity|October 28, 1998
Biotherapy with the pineal immunomodulating hormone melatonin versus melatonin plus aloe vera in untreatable advanced solid neoplasmsP Lissoni, L Giani, S Zerbini, et al.
British Journal of Cancer|October 1, 1989
Serum levels of soluble interleukin-2 receptors and their relation to lymphocyte subpopulations in patients with metastatic solid tumoursP Lissoni, S Barni, R Rescaldani, et al.
European Journal of Cancer & Clinical Oncology|May 1, 1989
Endocrine and immune effects of melatonin therapy in metastatic cancer patientsP Lissoni, S Barni, S Crispino, et al.
Oncology Reports|May 20, 2011
Modulation of cytokine production from TH2-lymphocytes and monocytes by the pineal neurohormone melatoninP Lissoni, S Pittalis, F Rovelli, et al.
The International Journal of Biological Markers|October 1, 1989
Serum levels of interleukin-2 in cancer patients: preliminary considerationsP Lissoni, S Viviani, A Santoro, et al.
The International Journal of Biological Markers|April 1, 1995
Influence of presurgical idiopathic hyperprolactinemia on relapse rate in operable breast cancerM Cazzaniga, P Lissoni, A Ardizzoia, et al.
Journal of Pineal Research|June 26, 2003
Five years survival in metastatic non-small cell lung cancer patients treated with chemotherapy alone or chemotherapy and melatonin: a randomized trialP Lissoni, M Chilelli, S Villa, et al.
Natural Immunity|November 4, 2000
Immunomodulatory effects of IL-12 in relation to the pineal endocrine function in metastatic cancer patientsP Lissoni, F Rovelli, L Giani, et al.
Pageof 29

Showing results (31-40 of 287) with videos related to

Sort By:
Pageof 29
Journal of Experimental & Clinical Cancer Research : CR|January 23, 1999
Possible biological indicators of the response to recombinant tumour necrosis factor alpha in patients with advanced neoplasmsR Braczkowski, B Zubelewicz, W Romanowski, et al.
Journal of Pineal Research|April 1, 1992
Normalization of the light/dark rhythm of melatonin after prolonged subcutaneous administration of interleukin-2 in advanced small cell lung cancer patientsS Viviani, P Bidoli, S Spinazzé, et al.
Natural Immunity|October 28, 1998
Biotherapy with the pineal immunomodulating hormone melatonin versus melatonin plus aloe vera in untreatable advanced solid neoplasmsP Lissoni, L Giani, S Zerbini, et al.
British Journal of Cancer|October 1, 1989
Serum levels of soluble interleukin-2 receptors and their relation to lymphocyte subpopulations in patients with metastatic solid tumoursP Lissoni, S Barni, R Rescaldani, et al.
European Journal of Cancer & Clinical Oncology|May 1, 1989
Endocrine and immune effects of melatonin therapy in metastatic cancer patientsP Lissoni, S Barni, S Crispino, et al.
Oncology Reports|May 20, 2011
Modulation of cytokine production from TH2-lymphocytes and monocytes by the pineal neurohormone melatoninP Lissoni, S Pittalis, F Rovelli, et al.
The International Journal of Biological Markers|October 1, 1989
Serum levels of interleukin-2 in cancer patients: preliminary considerationsP Lissoni, S Viviani, A Santoro, et al.
The International Journal of Biological Markers|April 1, 1995
Influence of presurgical idiopathic hyperprolactinemia on relapse rate in operable breast cancerM Cazzaniga, P Lissoni, A Ardizzoia, et al.
Journal of Pineal Research|June 26, 2003
Five years survival in metastatic non-small cell lung cancer patients treated with chemotherapy alone or chemotherapy and melatonin: a randomized trialP Lissoni, M Chilelli, S Villa, et al.
Natural Immunity|November 4, 2000
Immunomodulatory effects of IL-12 in relation to the pineal endocrine function in metastatic cancer patientsP Lissoni, F Rovelli, L Giani, et al.
Pageof 29